Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency-Reference-Cited by-同舟云学术

Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency

Published:2022-04-21 Issue:5 Volume:24 Page:833-842
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Anker Stefan D.¹²³,Ponikowski Piotr²,Khan Muhammad Shahzeb⁴,Friede Tim⁵,Jankowska Ewa A.²,Fabien Vincent⁶,Goehring Udo‐Michael⁶,Metra Marco⁷,Piña Ileana L.⁸,Coats Andrew J.S.⁹,Rosano Giuseppe¹⁰,Dorigotti Fabio⁶,Comin‐Colet Josep¹¹,Van Veldhuisen Dirk J.¹²,Filippatos Gerasimos S.¹³¹⁴,Butler Javed¹⁵

Affiliation:

1. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Center for Cardiovascular Research (DZHK) partner site Berlin Charité Universitätsmedizin Berlin Berlin Germany

2. Institute of Heart Diseases Wroclaw Medical University Wroclaw Poland

3. Institute of Heart Diseases University Hospital in Wroclaw Poland

4. Division of Cardiology Duke University Medical Center Durham NC USA

5. Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Göttingen partner site University Medical Center Göttingen Göttingen Germany

6. Vifor Pharma Ltd. Glattbrugg Switzerland

7. Cardiology University and Civil Hospital Brescia Italy

8. Central Michigan University Mount Pleasant MI USA

9. University of Warwick Coventry UK

10. Centre for Clinical and Basic Research, Department of Medical Sciences IRCCS San Raffaele Pisana Rome Italy

11. Department of Cardiology Bellvitge University Hospital; IDIBELL, University of Barcelona, Hospitalet de Llobregat Barcelona Spain

12. Department of Cardiology, University of Groningen University Medical Center Groningen Groningen The Netherlands

13. Medical School University of Cyprus Nicosia Cyprus

14. School of Medicine of National and Kapodistrian University of Athens Athens University Hospital Attikon Athens Greece

15. Department of Medicine University of Mississippi Jackson MS USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2491

Reference26 articles.

1. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure

2. Iron deficiency: an emerging therapeutic target in heart failure

3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency

5. US Food and Drug Administration.Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry June2019.https://www.fda.gov/media/128372/download. Accessed 30 Mar 2022.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of three mechanistic pathways for iron-deficient heart failure;European Heart Journal;2024-05-11

2. Iron Status and Risk of Heart Disease, Stroke, and Diabetes: A Mendelian Randomization Study in European Adults;Journal of the American Heart Association;2024-03-19

3. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial;American Heart Journal;2023-12

4. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial;Cardiovascular Diabetology;2023-08-17

5. Ironing out the wrinkles: Unanswered questions in intravenous iron repletion in heart failure;European Journal of Heart Failure;2023-05-25